These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 12948999)

  • 21. Donepezil for vascular cognitive impairment.
    Malouf R; Birks J
    Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rivastigmine for Alzheimer's disease.
    Birks J; Iakovidou V; Tsolaki M
    Cochrane Database Syst Rev; 2000; (2):CD001191. PubMed ID: 10796621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive stimulation therapy (CST) for people with dementia--who benefits most?
    Aguirre E; Hoare Z; Streater A; Spector A; Woods B; Hoe J; Orrell M
    Int J Geriatr Psychiatry; 2013 Mar; 28(3):284-90. PubMed ID: 22573599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of an interactive cycling training on cognitive functioning in older adults with mild dementia: study protocol for a randomized controlled trial.
    Karssemeijer EG; Bossers WJ; Aaronson JA; Kessels RP; Olde Rikkert MG
    BMC Geriatr; 2017 Mar; 17(1):73. PubMed ID: 28327083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Individual cognitive stimulation therapy for people with intellectual disability and dementia: protocol of a feasibility randomised controlled trial.
    Ali A; Brown E; Spector A; Aguirre E; Hassiotis A
    BMJ Open; 2018 Dec; 8(12):e022136. PubMed ID: 30530576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rivastigmine for vascular cognitive impairment.
    Birks J; McGuinness B; Craig D
    Cochrane Database Syst Rev; 2013 May; (5):CD004744. PubMed ID: 23728651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis.
    Knapp M; Thorgrimsen L; Patel A; Spector A; Hallam A; Woods B; Orrell M
    Br J Psychiatry; 2006 Jun; 188():574-80. PubMed ID: 16738349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive Stimulation Therapy for Older Adults With Mild-to-Moderate Dementia in Italy: Effects on Cognitive Functioning, and on Emotional and Neuropsychiatric Symptoms.
    Carbone E; Gardini S; Pastore M; Piras F; Vincenzi M; Borella E
    J Gerontol B Psychol Sci Soc Sci; 2021 Oct; 76(9):1700-1710. PubMed ID: 33437991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive rehabilitation for Parkinson’s disease dementia: a study protocol for a pilot randomised controlled trial.
    Hindle JV; Watermeyer TJ; Roberts J; Martyr A; Lloyd-Williams H; Brand A; Gutting P; Hoare Z; Edwards RT; Clare L
    Trials; 2016 Mar; 17():152. PubMed ID: 27000036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Field-testing phase of the development of individual cognitive stimulation therapy (iCST) for dementia.
    Yates LA; Orgeta V; Leung P; Spector A; Orrell M
    BMC Health Serv Res; 2016 Jul; 16():233. PubMed ID: 27391958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.
    Small G; Erkinjuntti T; Kurz A; Lilienfeld S
    CNS Drugs; 2003; 17(12):905-14. PubMed ID: 12962529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins for the treatment of dementia.
    McGuinness B; O'Hare J; Craig D; Bullock R; Malouf R; Passmore P
    Cochrane Database Syst Rev; 2010 Aug; (8):CD007514. PubMed ID: 20687089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance Cognitive Stimulation Therapy (CST) in practice: study protocol for a randomized controlled trial.
    Streater A; Spector A; Aguirre E; Hoe J; Hoare Z; Woods R; Russell I; Orrell M
    Trials; 2012 Jun; 13():91. PubMed ID: 22735077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individual Cognitive Stimulation Therapy for dementia (iCST): study protocol for a randomized controlled trial.
    Orrell M; Yates LA; Burns A; Russell I; Woods RT; Hoare Z; Moniz-Cook E; Henderson C; Knapp M; Spector A; Orgeta V
    Trials; 2012 Sep; 13():172. PubMed ID: 22998983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of vitamin B6 on cognition.
    Malouf R; Grimley Evans J
    Cochrane Database Syst Rev; 2003; (4):CD004393. PubMed ID: 14584010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive Stimulation Therapy for Dementia.
    Rai H; Yates L; Orrell M
    Clin Geriatr Med; 2018 Nov; 34(4):653-665. PubMed ID: 30336993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selegiline for Alzheimer's disease.
    Birks J; Flicker L
    Cochrane Database Syst Rev; 2000; (2):CD000442. PubMed ID: 10796544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.
    Dubois B; Tolosa E; Katzenschlager R; Emre M; Lees AJ; Schumann G; Pourcher E; Gray J; Thomas G; Swartz J; Hsu T; Moline ML
    Mov Disord; 2012 Sep; 27(10):1230-8. PubMed ID: 22915447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
    Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ
    Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.